Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11993653 Antibodies and methods of use thereof
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
June 7, 2019
0
Date of Patent
May 28, 2024
0
Patent Application Number
16435175
0
Patent Citations
US Patent 8354509 Antibodies to human programmed death receptor PD-1
0
US Patent 9358289 Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4 antibodies
0
US Patent 9381244 VISTA modulators for diagnosis and treatment of cancer
0
US Patent 9394365 Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
0
US Patent 9499603 PD-1 antibodies
0
US Patent 9580504 Pidilizumab monoclonal antibody therapy following stem cell transplantation
0
US Patent 9605070 Antibody molecules to TIM-3 and uses thereof
0
US Patent 9676853 Antigen binding proteins that bind PD-1
0
US Patent 9683048 Antibody molecules to PD-1 and uses thereof
0
US Patent 9701749 Therapeutic agent for autoimmune diseases comprising PD-1 agonist
0
•••
Patent Inventor Names
Jedd David Wolchok
0
Nicholas Stuart Wilson
0
Jean-Marie Cuillerot
0
Roberta Zappasodi
0
Olga Shebanova
0
David Schaer
0
Igor Proscurshim
0
David Adam Savitsky
0
Cornelia Anne Mundt
0
Rikke Baek Holmgaard
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11993653
0
Patent Primary Examiner
Marianne P Allen
0
Find more entities like US Patent 11993653 Antibodies and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE